News
Vinay Prasad was supposed to be the guy who kept Big Pharma in check. Now he’s gone.
Sources also say that the administration plans to split CBER in two, with one of the section focused entirely on vaccines.
Vinay Prasad, a top regulator at the US Food and Drug Administration, left the agency after a short-lived tenure that ended ...
The immediate ebullient reaction to Vinay Prasad’s ouster is understandable, and may ultimately be the correct one, Adam ...
Prasad came to the Food & Drug Administration in May, hoping to set high, evidence-based standards for new medicines. He didn't even last three months. The industry's power has never been clearer.
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
Alnylam Pharma raised its revenue outlook as its heart drug sees quick uptake. Biogen, Argenx, Sanofi, and Bristol Myers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results